C

Carespan Health Inc
XTSX:CSPN

Watchlist Manager
Carespan Health Inc
XTSX:CSPN
Watchlist
Price: 0.02 CAD Market Closed
Market Cap: CA$952.4k

Relative Value

CSPN doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of CSPN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CSPN Relative Value
Base Case
Not Available
C
Worst Case
Base Case
Best Case

Multiples Across Competitors

CSPN Competitors Multiples
Carespan Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Carespan Health Inc
XTSX:CSPN
952.3k CAD 0 0 0 0
US
GE Vernova LLC
NYSE:GEV
223.7B USD 0 0 0 0
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
97.3B ZAR 5.6 10.4 14.2 14.2
CH
Galderma Group AG
SIX:GALD
36.9B CHF 0 0 0 0
US
CoreWeave Inc
NASDAQ:CRWV
37B USD 0 0 0 0
US
Coupang Inc
F:788
29.2B EUR 1 168.1 30.6 64.1
US
Symbotic Inc
NASDAQ:SYM
30.3B USD 12.6 -2 778.5 -3 642.5 -585.2
ZA
Vukile Property Fund Ltd
JSE:VKE
28.6B ZAR 5.4 6.6 17.1 17.1
ZA
Fortress Real Estate Investments Ltd
JSE:FFB
28.2B ZAR 4.7 10.5 12.3 12.3
P/S Multiple
Revenue Growth P/S to Growth
CA
C
Carespan Health Inc
XTSX:CSPN
Average P/S: 63.5
Not Available
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
14%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
5.6
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
15%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
1
12%
0.1
US
Symbotic Inc
NASDAQ:SYM
12.6
26%
0.5
ZA
V
Vukile Property Fund Ltd
JSE:VKE
5.4
-24%
N/A
ZA
F
Fortress Real Estate Investments Ltd
JSE:FFB
4.7
-5%
N/A
P/E Multiple
Earnings Growth PEG
CA
C
Carespan Health Inc
XTSX:CSPN
Average P/E: 843.3
Not Available
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
10.4
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
44%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
168.1
105%
1.6
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 778.5 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
6.6
-5%
N/A
ZA
F
Fortress Real Estate Investments Ltd
JSE:FFB
10.5
0%
N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
C
Carespan Health Inc
XTSX:CSPN
Average EV/EBITDA: 698.3
Not Available
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
72%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
14.2
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
25%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
30.6
55%
0.6
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 642.5 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
17.1
12%
1.4
ZA
F
Fortress Real Estate Investments Ltd
JSE:FFB
12.3
5%
2.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
C
Carespan Health Inc
XTSX:CSPN
Average EV/EBIT: 729
Not Available
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
93%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
14.2
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
34%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
64.1
82%
0.8
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -585.2 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
17.1
10%
1.7
ZA
F
Fortress Real Estate Investments Ltd
JSE:FFB
12.3
5%
2.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett